DOI: 10.1055/s-00000077

Seminars in Thrombosis and Hemostasis

Issue 02 · Volume 30 · April 2004 DOI: 10.1055/s-002-3340 Gene Therapy in Hemophilia A and B in Animals and Humans: Current Status and Perspective Editor in Chief Eberhard F Mammen M.D., Guest Editors Thierry VandenDriessche Ph.D. Marinee K.L. Chuah Ph.D.

Post-Test Questions

C-1
TUFTS UNIVERSITY SCHOOL OF MEDICINE OFFICE OF CONTINUING EDUCATION ACCREDITATION INFORMATION

PREFACE

157
Mammen, Eberhard F.: Gene Therapy in Hemophilia A and B

161
Couto, Linda B.: Preclinical Gene Therapy Studies for Hemophilia Using Adeno-Associated Virus (AAV) Vectors
173
Thorrez, Lieven; VandenDriessche, Thierry; Collen, Désiré; Chuah, Marinee K. L.: Preclinical Gene Therapy Studies for Hemophilia Using Adenoviral Vectors
185
Damme, An Van; Chuah, Marinee K. L.; Collen, Désiré; VandenDriessche, Thierry: Onco-Retroviral and Lentiviral Vector-Based Gene Therapy for Hemophilia: Preclinical Studies
197
Gómez-Vargas, Andrew; Hortelano, Gonzalo: Nonviral Gene Therapy Approaches to Hemophilia
205
Rawle, Fiona E. M.; Lillicrap, David: Preclinical Animal Models for Hemophilia Gene Therapy: Predictive Value and Limitations
215
Herzog, Roland W.; Dobrzynski, Eric: Immune Implications of Gene Therapy for Hemophilia
227
Pipe, Steven W.: Coagulation Factors with Improved Properties for Hemophilia Gene Therapy
239
Ragni, Margaret V.: Hemophilia Gene Transfer: Comparison with Conventional Protein Replacement Therapy
249
Collen, Désiré; VandenDriessche, Thierry; Chuah, Marinee K. L.: Clinical Gene Transfer Studies for Hemophilia A
257
High, Katherine A.: Clinical Gene Transfer Studies for Hemophilia B